Structure of Shroom domain 2 reveals a three-segmented coiled-coil required for dimerization, Rock binding, and apical constriction

Molecular Biology of the Cell

Volumn 23, Issue 11, 2012, Pages 2131-2142

  Mohan, Swarna ^a   Rizaldy, Ryan ^a   Das, Debamitra ^a   Bauer, Robert J ^a   Heroux, Annie ^b   Trakselis, Michael A ^a   Hildebrand, Jeffrey D ^a   VanDemark, Andrew P ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; DIMER; MYOSIN ADENOSINE TRIPHOSPHATASE; PROTEIN SHROOM; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL SHAPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIMERIZATION; HUMAN; IN VIVO STUDY; INVERTEBRATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; VERTEBRATE;

ANIMALS; CELL POLARITY; CONSERVED SEQUENCE; CRYSTALLOGRAPHY, X-RAY; CYTOSKELETAL PROTEINS; DOGS; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; HUMANS; MICE; MICROFILAMENT PROTEINS; MUTATION; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RHO-ASSOCIATED KINASES; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; INVERTEBRATA; VERTEBRATA;

EID: 84861716217     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-11-0937     Document Type: Article

References (49)

1. Adams PD et al. (2010). PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 213-221.
2. Amano M, Chihara K, Nakamura N, Kaneko T, Matsuura Y, Kaibuchi K (1999). The COOH terminus of Rho-kinase negatively regulates Rho-kinase activity. J Biol Chem 274, 32418-32424.
3. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K (1996a). Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271, 20246-20249. (Pubitemid 26281788)
4. Amano M, Mukai H, Ono Y, Chihara K, Matsui T, Hamajima Y, Okawa K, Iwamatsu A, Kaibuchi K (1996b). Identification of a putative target for Rho as the serine-threonine kinase protein kinase N. Science 271, 648-650. (Pubitemid 26052909)
5. Biswas PS, Gupta S, Chang E, Bhagat G, Pernis AB (2011). Aberrant ROCK activation promotes the development of type I diabetes in NOD mice. Cell Immunol 266, 111-115.
6. Blumenstein L, Ahmadian MR (2004). Models of the cooperative mechanism for Rho effector recognition: implications for RhoA-mediated effector activation. J Biol Chem 279, 53419-53426. (Pubitemid 40051846)
7. Bolinger C, Zasadil L, Rizaldy R, Hildebrand J (2010). Specific isoforms of Drosophila Shroom define spatial requirements for the induction of apical constriction. Dev Dyn 239, 2078-2093.
8. Chung MI, Nascone-Yoder NM, Grover SA, Drysdale TA, Wallingford JB (2010). Direct activation of Shroom3 transcription by Pitx proteins drives epithelial morphogenesis in the developing gut. Development 137, 1339-1349.
9. Connolly MJ, Aaronson PI (2011). Key role of the RhoA/Rho kinase system in pulmonary hypertension. Pulm Pharmacol Ther 24, 1-14.
10. Davis IW et al. (2007). MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35, W375-W383.
11. Dietz ML, Bernaciak TM, Vendetti F, Kielec JM, Hildebrand JD (2006). Differential actin-dependent localization modulates the evolutionarily conserved activity of Shroom family proteins. J Biol Chem 281, 20542-20554. (Pubitemid 44065826)
12. Dong M, Yan BP, Liao JK, Lam YY, Yip GW, Yu CM (2011). Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases. Drug Discov Today 15, 622-629.
13. Dvorsky R, Blumenstein L, Vetter IR, Ahmadian MR (2004). Structural insights into the interaction of ROCKI with the switch regions of RhoA. J Biol Chem 279, 7098-7104. (Pubitemid 38248856)
14. Emsley P, Cowtan K (2004). Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126-2132. (Pubitemid 41742764)
15. Fairbank PD, Lee C, Ellis A, Hildebrand JD, Gross JM, Wallingford JB (2006). Shroom2 (APXL) regulates melanosome biogenesis and localization in the retinal pigment epithelium. Development 133, 4109-4118. (Pubitemid 44756203)
16. Farber MJ, Rizaldy R, Hildebrand JD (2011). Shroom2 regulates contractility to control endothelial morphogenesis. Mol Biol Cell 22, 795-805.
17. Gouet P, Courcelle E, Stuart DI, Metoz F (1999). ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15, 305-308. (Pubitemid 29213756)
18. Hagens O, Ballabio A, Kalscheuer V, Kraehenbuhl JP, Schiaffino MV, Smith P, Staub O, Hildebrand J, Wallingford JB (2006a). A new standard nomenclature for proteins related to Apx and Shroom. BMC Cell Biol 7, 18.
19. Hagens O et al. (2006b). Disruptions of the novel KIAA1202 gene are associated with X-linked mental retardation. Hum Genet 118, 578-590.
20. Haigo SL, Hildebrand JD, Harland RM, Wallingford JB (2003). Shroom induces apical constriction and is required for hingepoint formation during neural tube closure. Curr Biol 13, 2125-2137. (Pubitemid 38024937)
21. Hara Y et al. (2011). Rho and Rho-kinase activity in adipocytes contributes to a vicious cycle in obesity that may involve mechanical stretch. Sci Signal 4, ra3.
22. Hildebrand JD (2005). Shroom regulates epithelial cell shape via the apical positioning of an actomyosin network. J Cell Sci 118, 5191-5203.
23. Hildebrand JD, Soriano P (1999). Shroom, a PDZ domain-containing actin-binding protein, is required for neural tube morphogenesis in mice. Cell 99, 485-497.
24. Ikebe M, Koretz J, Hartshorne DJ (1988). Effects of phosphorylation of light chain residues threonine 18 and serine 19 on the properties and conformation of smooth muscle myosin. J Biol Chem 263, 6432-6437.
25. Ishizaki T et al. (1996). The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J 15, 1885-1893. (Pubitemid 26119224)
26. Jacobs M, Hayakawa K, Swenson L, Bellon S, Fleming M, Taslimi P, Doran J (2006). The structure of dimeric ROCK I reveals the mechanism for ligand selectivity. J Biol Chem 281, 260-268. (Pubitemid 43671185)
27. Kawano Y, Fukata Y, Oshiro N, Amano M, Nakamura T, Ito M, Matsumura F, Inagaki M, Kaibuchi K (1999). Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J Cell Biol 147, 1023-1038.
28. Kimura K et al. (1996). Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273, 245-248. (Pubitemid 26285892)
29. Komander D, Garg R, Wan PT, Ridley AJ, Barford D (2008). Mechanism of multi-site phosphorylation from a ROCK-I:RhoE complex structure. EMBO J 27, 3175-3185.
30. Kottgen A et al. (2009). Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 41, 712-717.
31. Lee C, Le MP, Wallingford JB (2009). The shroom family proteins play broad roles in the morphogenesis of thickened epithelial sheets. Dev Dyn 238, 1480-1491.
32. Liu X, Choy E, Hornicek FJ, Yang S, Yang C, Harmon D, Mankin H, Duan Z (2011). ROCK1 as a potential therapeutic target in osteosarcoma. J Orthop Res 29, 1259-1266.
33. Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K (1996). Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J 15, 2208-2216. (Pubitemid 26141137)
34. Moussavi RS, Kelley CA, Adelstein RS (1993). Phosphorylation of vertebrate nonmuscle and smooth muscle myosin heavy chains and light chains. Mol Cell Biochem 127-128, 219-227. (Pubitemid 24032668)
35. Nishimura T, Takeichi M (2008). Shroom3-mediated recruitment of Rho kinases to the apical cell junctions regulates epithelial and neuroepithelial planar remodeling. Development 135, 1493-1502. (Pubitemid 351753639)
36. Otwinowski Z, Minor W (1997). Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol 276, 307-326. (Pubitemid 27085611)
37. Plageman TF Jr, Chung MI, Lou M, Smith AN, Hildebrand JD, Wallingford JB, Lang RA (2010). Pax6-dependent Shroom3 expression regulates apical constriction during lens placode invagination. Development 137, 405-415.
38. Plageman TF Jr, Zacharias AL, Gage PJ, Lang RA (2011). Shroom3 and a Pitx2-N-cadherin pathway function cooperatively to generate asymmetric cell shape changes during gut morphogenesis. Dev Biol 357, 227-234.
39. Risler JL, Delorme MO, Delacroix H, Henaut A (1988). Amino acid substitutions in structurally related proteins. A pattern recognition approach. Determination of a new and efficient scoring matrix. J Mol Biol 204, 1019-1029. (Pubitemid 19050665)
40. Sheldrick GM (2008). A short history of SHELX. Acta Crystallogr A 64, 112-122.
41. Shimizu T, Ihara K, Maesaki R, Amano M, Kaibuchi K, Hakoshima T (2003). Parallel coiled-coil association of the RhoA-binding domain in Rho-kinase. J Biol Chem 278, 46046-46051. (Pubitemid 37432754)
42. Studier FW (2005). Protein production by auto-induction in high density shaking cultures. Protein Expr Purif 41, 207-234.
43. Taylor J, Chung KH, Figueroa C, Zurawski J, Dickson HM, Brace EJ, Avery AW, Turner DL, Vojtek AB (2008). The scaffold protein POSH regulates axon outgrowth. Mol Biol Cell 19, 5181-5192.
44. Trakselis MA, Alley SC, Ishmael FT (2005). Identification and mapping of protein-protein interactions by a combination of cross-linking, cleavage, and proteomics. Bioconjug Chem 16, 741-750.
45. Tu D, Li Y, Song HK, Toms AV, Gould CJ, Ficarro SB, Marto JA, Goode BL, Eck MJ (2011). Crystal structure of a coiled-coil domain from human ROCK I. PLoS One 6, e18080.
46. Wen W, Liu W, Yan J, Zhang M (2008). Structure basis and unconventional lipid membrane binding properties of the PH-C1 tandem of Rho kinases. J Biol Chem 283, 26263-26273.
47. Yamaguchi H, Kasa M, Amano M, Kaibuchi K, Hakoshima T (2006a). Molecular mechanism for the regulation of Rho-kinase by dimerization and its inhibition by fasudil. Structure 14, 589-600. (Pubitemid 43363491)
48. Yamaguchi H, Miwa Y, Kasa M, Kitano K, Amano M, Kaibuchi K, Hakoshima T (2006b). Structural basis for induced-fit binding of Rho-kinase to the inhibitor Y-27632. J Biochem 140, 305-311.
49. Zucker F, Champ PC, Merritt EA (2010). Validation of crystallographic models containing TLS or other descriptions of anisotropy. Acta Crystallogr D Biol Crystallogr 66, 889-900.